Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$11.06 +0.08 (+0.73%)
As of: Oct 21, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Repayments (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' Long-Term Debt Repayments came in at $15 million for FY2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends

  • Long-Term Debt Repayments carries a three-year compound annual growth rate of 44.2% (FY2022 to FY2025).
  • The FY2025 figure represents the lowest annual Long-Term Debt Repayments since FY2022.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $47.36 million in FY2023 (+847.3%) and $5 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Arcturus Therapeutics Holdings 314.64 Mn -499.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 20.00 Mn
Mar 31, 2023 27.36 Mn
Dec 31, 2022 3.00 Mn
API Access

Arcturus Therapeutics Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ARCT&period=max&api_key=YOUR_API_KEY